Saakshi Medtech & Panels

Saakshi Medtech & Panels

190.80
+4.60
(2.47%)
Market Cap
336.90 Cr
EPS
2.67
PE Ratio
-
Dividend Yield
0.00 %
52 Week High
277.00
52 Week Low
118.00
PB Ratio
-
Debt to Equity
0.28
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,143.50
#1 90,307.50
40.67
14,444.50
69.56
#1 1,969
92.70
54.20
1,070.20
48,241.90
46.03
6,518.75
116.74
876
55.30
51.56
9,669.50
38,840.80
44.01
#1 18,680.60
15.07
821
29.83
66.36
355.95
10,818.30
35.35
2,442.01
56.22
333
407.41
44.14
5,235.60
5,989.60
40.67
639.60
42.11
147
121.60
49.82
1,375.80
5,806.70
38.66
575.46
32.67
194
182.42
53.37
823.85
5,478.20
86.42
1,098.13
-8.05
66
242.25
44.87
2,193.65
4,457.30
28.11
987.17
#1 184.09
154
-
46.62
199.55
3,434.30
122.42
168.36
-107.14
28
#1 2,150.00
46.01
3,001.70
3,392.90
#1 24.66
1,901.69
31.99
134
16.74
46.15

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-33.06 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
38
62
60
92
122
123
92
0
Expenses
34
50
54
76
102
102
82
0
EBITDA
4
12
6
16
21
20
10
0
Operating Profit %
10 %
18 %
10 %
17 %
17 %
16 %
11 %
0 %
Depreciation
1
2
2
2
3
4
4
0
Interest
1
2
2
1
2
2
0
0
Profit Before Tax
2
8
3
13
17
15
7
0
Tax
1
2
1
3
4
4
2
0
Net Profit
2
6
2
9
12
11
5
0
EPS in ₹
61.88
222.60
80.96
7.21
9.52
6.40
2.67
0.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
39
48
56
65
93
131
131
Fixed Assets
15
23
22
26
34
62
73
Current Assets
21
23
31
37
56
66
54
Capital Work in Progress
2
0
0
0
0
0
13
Investments
0
0
0
0
0
0
20
Other Assets
22
26
34
39
59
69
0
Total Liabilities
39
48
56
65
93
131
131
Current Liabilities
21
22
27
28
41
21
19
Non Current Liabilities
6
9
9
8
10
17
15
Total Equity
12
18
20
30
42
93
98
Reserve & Surplus
9
15
18
27
40
76
80
Share Capital
3
3
3
3
3
18
18

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
2
1
-2
2
12
Investing Activities
-9
-7
-1
-6
-11
-31
Operating Activities
0
11
0
11
11
7
Financing Activities
8
-3
2
-7
2
36

Share Holding

% Holding
Sept 2023
Oct 2023
Dec 2023
Mar 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
73.63 %
FIIs
0.00 %
0.00 %
1.63 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.07 %
0.07 %
3.73 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.18 %
11.18 %
17.88 %
22.07 %
22.60 %
22.64 %
22.37 %
Others
15.12 %
15.12 %
3.13 %
4.30 %
3.77 %
3.73 %
4.00 %
No of Share Holders
1,705
1,706
1,358
1,389
1,780
1,985
1,914

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 129.40 130.70
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 218.00 218.50
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 267.90 242.60

Technical Indicators

RSI(14)
Neutral
52.29
ATR(14)
Less Volatile
7.65
STOCH(9,6)
Neutral
32.56
STOCH RSI(14)
Oversold
15.90
MACD(12,26)
Bearish
-2.59
ADX(14)
Strong Trend
28.65
UO(9)
Bearish
54.43
ROC(12)
Downtrend But Slowing Down
-4.02
WillR(14)
Neutral
-59.17